Background: Incident heart failure (HF) is increased in persons with human
immunodeficiency virus (PHIV). Protease inhibitors (PIs) are associated with adverse …

Background Persons living with HIV are at a higher risk of cardiovascular disease despite
effective antiretroviral therapy and dramatic reductions in AIDS-related conditions. We …

With the advent and widespread use of antiretroviral therapy (ART), the epidemiology of
cardiomyopathy and heart failure (HF) associated with HIV infection is changing. Near …

Heart failure (HF) has been a known complication of HIV/AIDS for three decades. As the
treatment of HIV has changed, so has the epidemiology and pathophysiology of HF in …

Importance With improved survival, heart failure (HF) has become a major complication for
individuals with human immunodeficiency virus (HIV) infection. It is unclear if this risk …

Abstract Purpose People with HIV (PHIV) with access to modern antiretroviral therapy (ART)
face a two-fold increased risk of heart failure as compared with non-HIV-infected individuals …

HIV protease inhibitor (PI) therapy may be associated with cardiac and vascular
complications. We assessed the effects of PIs on cardiac function and structure. M-modc …

Objectives: The aim of this study was to determine the incidence of sudden cardiac death
(SCD) among persons living with human immunodeficiency virus infection (PHIV) with heart …

Background: Although the HIV can cause myocardial inflammation, the association of HIV
infection with subsequent development of heart failure (HF) has not been extensively …

Aims Human immunodeficiency virus infection (HIV) has been associated with cardiac
dysfunction that, if present, can negatively affect morbidity and mortality of HIV-infected …